Onconova Therapeutics Announces Additional Clinical Data Demonstrating Rigosertib's Monotherapy Activity in RDEB-Associated Squamous Cell Carcinoma
Stock Information for Onconova Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.